Hightower Clinical
Hightower Clinical is a physician-led clinical research organization based in Oklahoma City that conducts Phase I-IV clinical trials across oncology, cardiovascular, and numerous other therapeutic areas for pharmaceutical and biotech sponsors, having completed over 500 studies. The company also runs an oncology biorepository program and serves a tri-segment base of sponsors, physician investigators, and Oklahoma-area trial participants.
- Company typePrivate
- Founded2018
- HeadquartersOklahoma City, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Hightower Clinical does
Hightower Clinical is a physician-led clinical research organization (CRO) headquartered in Oklahoma City, Oklahoma, founded in 2018, that conducts Phase I-IV clinical trials on behalf of pharmaceutical sponsors and contract research organizations. The company executes studies across more than a dozen therapeutic areas — including oncology, cardiovascular, gastroenterology, dermatology, neurology, rheumatology, endocrinology, pulmonology, pain management, urology, orthopedics, podiatry, and pediatrics — and has completed over 500 trials cumulatively. Its technology and operational stack centers on multi-center trial management across multiple Oklahoma City research sites, a Patient Recruitment Database for participant matching, and dedicated oncology biorepository services supporting biomarker collection and early-detection research for diagnostics and biotech sponsors.
The business is structured around a tri-segment customer base. On the revenue side, the company contracts with pharmaceutical sponsors and CROs (Pfizer, Roche, AstraZeneca, Abbott, Amgen, Bristol-Myers Squibb, Takeda, Gilead, Biogen, Medtronic, Novartis, NovoCure, among others) to perform study execution, patient enrollment, data collection, and regulatory compliance. The company has built a physician investigator network that supplies principal investigators across its research sites, which are anchored by partnerships with CardioVascular Health Clinic, Frank C. Love Cancer Institute, and SSM Health Heart & Vascular. The third segment — clinical trial participants in the Oklahoma City area — is not a paying customer but is acquired via direct website enrollment, SEO-optimized study pages, and healthcare provider referrals; participants receive study-related care at no cost and may be compensated for time and travel.
Revenue is generated through professional services contracts for trial execution (study conduct, patient enrollment, data collection, regulatory compliance). Pricing is not publicly disclosed and no revenue figure is available in the source material. Operations are concentrated in Oklahoma, with a headquarters at 608 NW 9th St, Suite 5000, a secondary office at 13301 N. Meridian Avenue, Suite 502, and additional research sites across the metro; the company is privately held with no disclosed external investors, parent company, M&A activity, or funding rounds.
Hightower Clinical firmographics
Firmographics- Name
- Hightower Clinical
- Legal name
- Hightower Clinical
- Website
- https://hightowerclinical.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Hightower Clinical is a physician-led clinical research organization based in Oklahoma City that conducts Phase I-IV clinical trials across oncology, cardiovascular, and numerous other therapeutic areas for pharmaceutical and biotech sponsors, having completed over 500 studies. The company also runs an oncology biorepository program and serves a tri-segment base of sponsors, physician investigators, and Oklahoma-area trial participants.
- Ownership category
- akta.pro rank
Hightower Clinical industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)
Keywords
Where Hightower Clinical is headquartered
LocationHeadquarters
- HQ city
- Oklahoma City
- HQ country
- United States
- HQ region
- North America
Offices6 records
Markets served
Hightower Clinical business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Contract Research Services: Hightower Clinical generates revenue by conducting clinical trials on behalf of pharmaceutical sponsors and CROs. The company receives contract fees for study execution, patient enrollment, data collection, and regulatory compliance services across Phase I-IV trials.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels4 records
Hightower Clinical product offering
Product offeringCore offering
Hightower Clinical is a Clinical Research Organization (CRO) based in Oklahoma City that conducts Phase I-IV clinical trials across multiple therapeutic areas, including oncology, cardiovascular, gastroenterology, dermatology, neurology, rheumatology, endocrinology, pulmonology, pain management, pediatrics, urology, orthopedics, and podiatry, on behalf of pharmaceutical sponsors and CROs. The organization also provides oncology biorepository services for the collection, storage, and analysis of blood and tissue samples for biomarker research, along with patient recruitment services supported by patient recruitment databases. Hightower Clinical has completed over 500 clinical trials for sponsors such as Pfizer, Roche, AstraZeneca, Abbott, Amgen, Bristol-Myers Squibb, Takeda, Gilead, Biogen, and Medtronic.
Product overview
Hightower Clinical is a Clinical Research Organization (CRO) based in Oklahoma City, OK, founded in 2018. The company offers a unified platform of clinical research services conducting Phase I-IV clinical trials across multiple therapeutic areas. Their core offerings include oncology studies (including breast cancer, lung cancer, colorectal cancer), cardiovascular trials, gastroenterology research (Crohn's disease, ulcerative colitis), dermatology studies, neurology trials, rheumatology research, endocrinology studies, pulmonology trials, pain management research, pediatric studies, urology trials, orthopedic research, and podiatry studies. Additionally, they offer oncology biorepository services for biomarker collection and analysis. The company collaborates with pharmaceutical sponsors and CROs, having conducted over 500 clinical trials. Services include patient recruitment and enrollment management through their Patient Recruitment Databases.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Research Services (Phase I-IV) End-to-end Phase I-IV clinical trial execution across oncology, cardiovascular, gastroenterology, dermatology, rheumatology, pain management, pulmonology, urology, podiatry, orthopedics, neurology, endocrinology, and pediatrics, delivered to pharmaceutical sponsors and CROs.
- Oncology Biorepository Services Cancer biorepository clinical trials that collect and store tissue and blood samples for biomarker analysis, enabling early detection testing and more accurate diagnoses for sponsors conducting lung cancer, general oncology, and cancer biobank registry studies.
- Patient Recruitment Services Patient recruitment and enrollment management supported by Patient Recruitment Databases containing health information and demographic data, used to match individuals with relevant clinical studies for pharmaceutical sponsors.
- Cardiovascular Clinical Trials Clinical trial execution covering heart failure, hypertension, atrial fibrillation, hypertriglyceridemia, peripheral vascular disease, and device studies such as left atrial appendage occlusion and drug-eluting scaffolds.
- Gastroenterology Studies Clinical trials for Crohn's disease, ulcerative colitis, and Clostridium difficile infection, evaluating safety and efficacy of investigational drugs.
- Dermatology Clinical Trials Studies for atopic dermatitis, psoriasis, prurigo nodularis, and Gorlin syndrome, including pediatric psoriasis research.
- Endocrinology Studies Clinical trials for Graves' disease and peripheral neuropathic pain, exploring treatments for hormonal imbalances and metabolic disorders.
- Pulmonology Clinical Trials Studies for chronic obstructive pulmonary disease (COPD) and eosinophilic asthma, evaluating experimental medications for airway inflammation and lung function improvement.
- Pain Management Research Clinical trials evaluating neurostimulation systems for chronic leg and back pain, assessing efficacy, safety, comfort, and compliance.
- Pediatric Clinical Trials Research studies for infant development and pediatric populations, including iron-fortified formula studies following FDA guidelines.
- Urology Clinical Trials Studies for urinary tract infections, including phase 2 randomized trials evaluating new treatments in combination with antibiotics for drug-resistant infections.
- Orthopedic Research Clinical trials for knee osteoarthritis and plantar fibromatosis, evaluating intra-articular injections and investigational therapies for joint discomfort relief.
- Podiatry Clinical Trials Studies for plantar fibromatosis (Ledderhose disease), exploring investigational therapies to improve quality of life for patients with foot conditions.
- Metastatic Breast Cancer Research Clinical trials evaluating investigational drugs for estrogen receptor-positive, HER2-negative locally advanced or metastatic breast cancer.
- Non-Small Cell Lung Cancer Studies Clinical trials evaluating bispecific antibodies and other treatments for advanced NSCLC and solid tumors, including combination therapies with Osimertinib or chemotherapy.
- Neurology Research Studies Clinical trials for acute migraine, focal seizures, hypertension (Kardia 3), and major depressive disorder (MDD), evaluating investigational drugs across multiple dose ranges.
- Rheumatology Clinical Trials Studies for psoriatic arthritis, ANCA-associated vasculitis, and systemic lupus erythematosus (SLE), evaluating new investigational therapies.
Quantifiable outcome
- 500+ clinical trials completed across Phase I-IV
Companies that use Hightower Clinical
Customer profileNamed customers26 records
Segments3 records
Ideal customer profiles3 records
Hightower Clinical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Hightower Clinical partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core.
- JanssencorePharmaceutical sponsor partner for clinical trials conducted at Hightower Clinical research sites.
- Exact SciencescorePharmaceutical partner for clinical research collaboration.
- NovoCurecorePharmaceutical sponsor for clinical trials.
- NovartiscorePharmaceutical sponsor for clinical research studies.
- RochecorePharmaceutical sponsor for oncology and other clinical trials including metastatic breast cancer and lung cancer biorepository studies.
- PfizercoreMajor pharmaceutical sponsor conducting metastatic breast cancer, Crohn's disease, and ulcerative colitis clinical trials.
- GileadcorePharmaceutical sponsor for ulcerative colitis clinical trial.
- AmgencorePharmaceutical sponsor for dermatology and immunology clinical trials including atopic dermatitis, psoriasis, and ANCA vasculitis.
- AstraZenecacorePharmaceutical sponsor for cardiovascular clinical trials including heart failure study.
- AbbottcoreMedical device and pharmaceutical sponsor for atrial fibrillation, peripheral vascular disease, and Volt AFib studies.
- CardioVascular Health CliniccoreResearch site partner for cardiovascular clinical trials in Oklahoma City.
- Frank C. Love Cancer InstitutecoreResearch site partner for oncology clinical trials in Oklahoma City.
- SSM Health Heart & VascularcoreResearch site partner for cardiovascular clinical trials.
Scale indicators2 records
Recent moves5 records
Expansion highlights5 records
Hightower Clinical competitors and assessment
Company assessmentBroad incumbents
- ICON plc: Global CRO with broad therapeutic-area coverage including oncology, cardiovascular, and specialty indications. Competes directly for Phase I-IV trial contracts with major pharma sponsors.
- IQVIA: World's largest CRO with global site network and full Phase I-IV capabilities across oncology, cardio, GI, and other therapeutic areas Hightower serves. Competes for the same pharma sponsors but at vastly greater scale.
- Medpace: Mid-to-large full-service CRO running Phase I-IV trials across all major therapeutic areas including oncology and cardiovascular. Comparable as a sponsor-facing clinical trial execution partner, though Medpace operates globally with a tech-enabled model.
- PPD (Thermo Fisher Scientific): Global CRO now part of Thermo Fisher, offering full Phase I-IV trial services including oncology and cardiovascular. Direct competitor for sponsor trial contracts.
Direct peers
- Celerion: CRO with early-phase clinical trial capabilities and bioanalytical/biorepository services. Comparable to Hightower's biorepository and Phase I capabilities, especially in oncology.
- Worldwide Clinical Trials: Mid-sized CRO focused on Phase I-IV trials across multiple therapeutic areas including oncology, cardiovascular, and CNS. Closely comparable in scale and service mix to Hightower.
- Meridian Clinical Research: Multi-site clinical research organization operating community-based research sites across multiple therapeutic areas. Highly comparable operating model to Hightower's physician-practice-based site network.
- Clinipace Worldwide (now dMed Biopharmaceutical Services): Mid-sized CRO with multi-therapeutic trial execution capabilities including oncology and specialty areas. Comparable in service offering and sponsor mix.
- Firma Clinical Research: Smaller multi-therapeutic CRO offering Phase I-IV trial execution services to pharma sponsors. Comparable scale and business model to Hightower.
- Rho (now Veramed): Mid-sized CRO providing Phase I-IV clinical trial services across multiple therapeutic areas including oncology and specialty indications. Comparable in therapeutic breadth and sponsor relationships.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Hightower Clinical social profiles
Digital presenceHightower Clinical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Hightower Clinical leadership team
Management profileNumber of profiles
Profiles1 record
Hightower Clinical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Hightower Clinical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Hightower Clinical
What does Hightower Clinical do?
Hightower Clinical is a Clinical Research Organization (CRO) based in Oklahoma City that conducts Phase I-IV clinical trials across multiple therapeutic areas, including oncology, cardiovascular, gastroenterology, dermatology, neurology, rheumatology, endocrinology, pulmonology, pain management, pediatrics, urology, orthopedics, and podiatry, on behalf of pharmaceutical sponsors and CROs. The organization also provides oncology biorepository services for the collection, storage, and analysis of blood and tissue samples for biomarker research, along with patient recruitment services supported by patient recruitment databases. Hightower Clinical has completed over 500 clinical trials for sponsors such as Pfizer, Roche, AstraZeneca, Abbott, Amgen, Bristol-Myers Squibb, Takeda, Gilead, Biogen, and Medtronic.
Is Hightower Clinical a public or private company?
Hightower Clinical is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Hightower Clinical founded?
Hightower Clinical was founded in 2018. It employs 1 to 10 people.
Where is Hightower Clinical based?
Hightower Clinical is headquartered in Oklahoma City, United States, in the North America region.
How does Hightower Clinical make money?
One revenue line is on record: contract Research Services.
Who are Hightower Clinical's main competitors?
Broad incumbents on record are ICON plc, IQVIA, Medpace and PPD (Thermo Fisher Scientific). Direct peers are Celerion, Worldwide Clinical Trials, Meridian Clinical Research, Clinipace Worldwide (now dMed Biopharmaceutical Services), Firma Clinical Research and Rho (now Veramed).
Does Hightower Clinical have an API?
No public API is recorded for Hightower Clinical.
What industry is Hightower Clinical in?
Hightower Clinical's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 621511 and its SIC code is 8731.